– CNBC
Biogen’s Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
The FDA approved Biogen Inc's (NASDAQ:
CNBC Halftime Report Final Trades: Meta Platforms, Raytheon Technologies, EOG Resources & L3Harris Technologies
– CNBC
Related Posts
Capstone Green Energy Receives Second Follow-On Order For 5 C65 Microturbine Systems For Marcellus Wellhead Sites; No Terms Disclosed
Units Will Provide Clean, Reliable Power at Numerous Remote Site
Capstone Green Energy Corporation (NASDAQ:CGRN), a global leader in carbon reduction and on-site resilient green energy solutions, announced today
Rivian Shows Off ‘Enhanced Trip Planning’ A Day After Acquiring Mapping Company Iternio
Electric vehicle company Rivian Automotive Inc (NASDAQ:RIVN) on Thursday said that it now offers ‘enhanced trip planning’ via…
NetEase Board Approved a Dividend of $0.5250 per ADS for Q2 vs. $0.4650 per ADS for Q1
The board of directors has approved a dividend of US$0.1050 per share (US$0.5250 per ADS) for the second quarter of 2023 to holders of ordinary shares and holders of ADSs as of the close ofThe board of directors has approved a dividend of US$0.1050 per share (US$0.5250 per ADS) for the second quarter of 2023 to holders of ordinary shar